Stockreport

How Regaining Full Rights to Rett Syndrome Gene Therapy Has Changed Taysha (TSHA)'s Investment Story [Yahoo! Finance]

Taysha Gene Therapies, Inc.  (TSHA) 
PDF after the expiration of an option agreement with Astellas, following the submission of clinical trial data and receipt of Breakthrough Therapy designation from the FDA. [Read more]